Valneva SE (VALN) Accumulated Expenses (2020 - 2025)

Valneva SE (VALN) posted quarterly Accumulated Expenses of $14.4 million for Q4 2025, down 3.55% year-on-year from $14.9 million in Q4 2024, and down 3.55% on a QoQ basis from $14.9 million in Q4 2024.

Valneva SE (VALN) Accumulated Expenses (2020 - 2025) Analysis & Trends

Valneva SE (VALN) has reported Accumulated Expenses for 6 consecutive years, with $14.4 million the latest figure, recorded in Q4 2025.

  • Quarterly Accumulated Expenses fell 3.55% year-over-year to $14.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $14.4 million (down 3.55% YoY) and the FY2025 annual result came in at $14.4 million, down 3.55% from the prior year.
  • Accumulated Expenses fell to $14.4 million in Q4 2025 per VALN's latest filing, from $14.9 million in the prior quarter.
  • Over the last five years, Accumulated Expenses for VALN reached as high as $14.9 million in Q4 2024 and fell as low as $11.5 million in Q4 2021.
  • A 5-year average of $12.8 million and a median of $12.3 million in 2022 frame the typical range for Accumulated Expenses.
  • Annual changes were most pronounced in 2021 — Accumulated Expenses gained 21.7% — and 2025, when it dropped 3.55%.
  • Year by year, Accumulated Expenses stood at $11.5 million in 2021, then climbed by 6.7% to $12.3 million in 2022, then increased by 0.34% to $12.3 million in 2023, then rose by 21.19% to $14.9 million in 2024, then fell by 3.55% to $14.4 million in 2025.
  • According to Business Quant data, Accumulated Expenses over the past three periods registered $14.4 million, $14.9 million, and $11.6 million for Q4 2025, Q4 2024, and Q2 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Valneva SE 803.90 Mn 680.66 Mn 5.38 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 14.39 Mn
Dec 31, 2024 14.92 Mn
Jun 30, 2024 11.55 Mn
Dec 31, 2023 12.31 Mn
Dec 31, 2022 12.26 Mn
Dec 31, 2021 11.49 Mn
Dec 31, 2020 9.45 Mn